{
  "documentMetadata": {
    "title": "Otitis Media, Post-Intubation",
    "sourceFile": "Otitis Media, Post-Intubation.pdf",
    "lastUpdated": "2025-04-22"
  },
  "content": [
    {
      "type": "header",
      "level": 2,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Prevalence of true infection poorly defined.",
        "Otitis media that develops after > 48 hours of nasotracheal intubation."
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Pseudomonas sp.",
        "Klebsiella sp.",
        "Enterobacter sp."
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Primary Regimens"
    },
    {
      "type": "regimen",
      "regimenData": {
        "intent": "treatment",
        "strengthOfRecommendation": "Recommended",
        "components": [
          {
            "drug": "Ceftazidime",
            "dose": "2 gm",
            "route": "IV",
            "frequency": "q8h"
          },
          {
            "drug": "Cefepime",
            "dose": "2 gm",
            "route": "IV",
            "frequency": "q8h",
            "connector": "or"
          }
        ]
      }
    },
    {
      "type": "regimen",
      "regimenData": {
        "intent": "treatment",
        "strengthOfRecommendation": "Recommended",
        "components": [
          {
            "drug": "Imipenem",
            "dose": "0.5 gm",
            "route": "IV",
            "frequency": "q6h"
          },
          {
            "drug": "Meropenem",
            "dose": "1 gm",
            "route": "IV",
            "frequency": "q8h",
            "connector": "or"
          }
        ]
      }
    },
    {
      "type": "regimen",
      "regimenData": {
        "intent": "treatment",
        "strengthOfRecommendation": "Recommended",
        "components": [
          {
            "drug": "Piperacillin-tazobactam",
            "dose": "4.5 gm",
            "route": "IV",
            "frequency": "(over 4 hr) q8h"
          }
        ]
      }
    },
    {
      "type": "regimen",
      "regimenData": {
        "intent": "treatment",
        "strengthOfRecommendation": "Recommended",
        "components": [
          {
            "drug": "Ciprofloxacin",
            "dose": "400 mg",
            "route": "IV",
            "frequency": "q12h"
          }
        ]
      }
    },
    {
      "type": "header",
      "level": 2,
      "text": "Alternative Regimens"
    },
    {
      "type": "list",
      "items": [
        "None"
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Antimicrobial Stewardship"
    },
    {
      "type": "list",
      "items": [
        "Duration of therapy not well defined."
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "With intact tympanic membrane, pathogen may not be available for susceptibility testing; however, if a suspected pathogen is recovered, determine susceptibility to help inform therapy.",
        "Middle ear effusions are common in ICU patients and related to intubation and nasogastric tube placement."
      ]
    }
  ]
}